Advanced search
Publication Cover
OncoImmunology Volume 3, 2014 - Issue 11
Submit an article Journal homepage
1,615
Views
30
CrossRef citations to date
0
Altmetric
AUTHOR'S VIEW

Priming the pancreatic cancer tumor microenvironment for checkpoint-inhibitor immunotherapy

Eric R LutzDepartment of Oncology; Johns Hopkins University School of Medicine; Baltimore, MDUSA;The Sidney Kimmel Cancer Center; Johns Hopkins University School of Medicine, Baltimore, MDUSA;The Skip Viragh Center for Pancreatic Cancer Research and Clinical Care; Johns Hopkins University School of Medicine, Baltimore, MDUSA;The Sol Goldman Pancreatic Cancer Center; Johns Hopkins University School of Medicine, Baltimore, MDUSA
,
Heather KinkeadDepartment of Oncology; Johns Hopkins University School of Medicine; Baltimore, MDUSA;The Sidney Kimmel Cancer Center; Johns Hopkins University School of Medicine, Baltimore, MDUSA;The Skip Viragh Center for Pancreatic Cancer Research and Clinical Care; Johns Hopkins University School of Medicine, Baltimore, MDUSA;Graduate Program of Cellular and Molecular Medicine; Johns Hopkins University School of Medicine, Baltimore, MDUSA
,
Elizabeth M JaffeeDepartment of Oncology; Johns Hopkins University School of Medicine; Baltimore, MDUSA;The Sidney Kimmel Cancer Center; Johns Hopkins University School of Medicine, Baltimore, MDUSA;The Skip Viragh Center for Pancreatic Cancer Research and Clinical Care; Johns Hopkins University School of Medicine, Baltimore, MDUSA;The Sol Goldman Pancreatic Cancer Center; Johns Hopkins University School of Medicine, Baltimore, MDUSA;Department of Pathology
&
Lei ZhengDepartment of Oncology; Johns Hopkins University School of Medicine; Baltimore, MDUSA;The Sidney Kimmel Cancer Center; Johns Hopkins University School of Medicine, Baltimore, MDUSA;The Skip Viragh Center for Pancreatic Cancer Research and Clinical Care; Johns Hopkins University School of Medicine, Baltimore, MDUSA;The Sol Goldman Pancreatic Cancer Center; Johns Hopkins University School of Medicine, Baltimore, MDUSA;Department of Surgery; Johns Hopkins University School of Medicine, Baltimore, MDUSACorrespondence[email protected]
Article: e962401 | Received 22 Aug 2014, Accepted 30 Aug 2014, Published online: 31 Oct 2014

Citations (30)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Michael Karl Melzer, Yazid Resheq, Fatemeh Navaee & Alexander Kleger. (2023) The application of pancreatic cancer organoids for novel drug discovery. Expert Opinion on Drug Discovery 18:4, pages 429-444.
Read now
Julius Strauss, Ravi A. Madan & James L. Gulley. (2016) Considerations for the combination of anticancer vaccines and immune checkpoint inhibitors. Expert Opinion on Biological Therapy 16:7, pages 895-901.
Read now

Articles from other publishers (28)

Adrian Boicean, Dan Bratu, Ciprian Bacila, Ciprian Tanasescu, Radu Sorin Fleacă, Calin Ilie Mohor, Andra Comaniciu, Teodora Băluță, Mihai Dan Roman, Radu Chicea, Adrian Nicolae Cristian, Adrian Hasegan, Sabrina Birsan, Horațiu Dura & Cosmin Ioan Mohor. (2023) Therapeutic Perspectives for Microbiota Transplantation in Digestive Diseases and Neoplasia—A Literature Review. Pathogens 12:6, pages 766.
Crossref
Charu Aggarwal, Nabil F. Saba, Alain Algazi, Ammar Sukari, Tanguy Y. Seiwert, Missak Haigentz, Mercedes Porosnicu, Marcelo Bonomi, Jean Boyer, Mark T. Esser, Lily I. Cheng, Sonia Agrawal, Emily C. Jennings, Nicholas M. Durham, Karl Fraser, Delphine Lissa, Maozhen Gong, Natalia Ceaicovscaia, Amaya Gascó Hernández & Rakesh Kumar. (2023) Safety and Efficacy of MEDI0457 plus Durvalumab in Patients with Human Papillomavirus–Associated Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma. Clinical Cancer Research 29:3, pages 560-570.
Crossref
Keyu Li, Joseph A. Tandurella, Jessica Gai, Qingfeng Zhu, Su Jin Lim, Dwayne L. ThomasIIII, Tao Xia, Guanglan Mo, Jacob T. Mitchell, Janelle Montagne, Melissa Lyman, Ludmila V. Danilova, Jacquelyn W. Zimmerman, Benedict Kinny-Köster, Tengyi Zhang, Linda Chen, Alex B. Blair, Thatcher Heumann, Rose Parkinson, Jennifer N. Durham, Amol K. Narang, Robert A. Anders, Christopher L. Wolfgang, Daniel A. Laheru, Jin He, Arsen Osipov, Elizabeth D. Thompson, Hao Wang, Elana J. Fertig, Elizabeth M. Jaffee & Lei Zheng. (2022) Multi-omic analyses of changes in the tumor microenvironment of pancreatic adenocarcinoma following neoadjuvant treatment with anti-PD-1 therapy. Cancer Cell 40:11, pages 1374-1391.e7.
Crossref
Manjiang Li, Wei Ding, Yuxu Wang, Yongbiao Ma & Futian Du. (2022) Development and validation of a gene signature for pancreatic cancer: based on inflammatory response–related genes. Environmental Science and Pollution Research 30:7, pages 17166-17178.
Crossref
Eric M. Anderson, Shant Thomassian, Jun Gong, Andrew Hendifar & Arsen Osipov. (2021) Advances in Pancreatic Ductal Adenocarcinoma Treatment. Cancers 13:21, pages 5510.
Crossref
Yu Zhang, Vidhi Chandra, Erick Riquelme Sanchez, Prasanta Dutta, Pompeyo R. Quesada, Amanda Rakoski, Michelle Zoltan, Nivedita Arora, Seyda Baydogan, William Horne, Jared Burks, Hanwen Xu, Perwez Hussain, Huamin Wang, Sonal Gupta, Anirban Maitra, Jennifer M. Bailey, Seyed J. Moghaddam, Sulagna Banerjee, Ismet Sahin, Pratip Bhattacharya & Florencia McAllister. (2020) Interleukin-17–induced neutrophil extracellular traps mediate resistance to checkpoint blockade in pancreatic cancer. Journal of Experimental Medicine 217:12.
Crossref
Chongxian Pan, Hongtao Liu, Elizabeth Robins, Wenru Song, Delong Liu, Zihai Li & Lei Zheng. (2020) Next-generation immuno-oncology agents: current momentum shifts in cancer immunotherapy. Journal of Hematology & Oncology 13:1.
Crossref
Padmanee Sharma, Russell K. Pachynski, Vivek Narayan, Aude Fléchon, Gwenaelle Gravis, Matthew D. Galsky, Hakim Mahammedi, Akash Patnaik, Sumit K. Subudhi, Marika Ciprotti, Burcin Simsek, Abdel Saci, Yanhua Hu, G. Celine Han & Karim Fizazi. (2020) Nivolumab Plus Ipilimumab for Metastatic Castration-Resistant Prostate Cancer: Preliminary Analysis of Patients in the CheckMate 650 Trial. Cancer Cell 38:4, pages 489-499.e3.
Crossref
Ke‐Yu Li, Jia‐Long Yuan, Diego Trafton, Jian‐Xin Wang, Nan Niu, Chun‐Hui Yuan, Xu‐Bao Liu & Lei Zheng. (2020) Pancreatic ductal adenocarcinoma immune microenvironment and immunotherapy prospects. Chronic Diseases and Translational Medicine 6:1, pages 6-17.
Crossref
Burak Uzunparmak & Ibrahim Halil Sahin. (2019) Pancreatic cancer microenvironment: a current dilemma. Clinical and Translational Medicine 8:1.
Crossref
Chin-King Looi, Felicia Fei-Lei Chung, Chee-Onn Leong, Shew-Fung Wong, Rozita Rosli & Chun-Wai Mai. (2019) Therapeutic challenges and current immunomodulatory strategies in targeting the immunosuppressive pancreatic tumor microenvironment. Journal of Experimental & Clinical Cancer Research 38:1.
Crossref
Eva Karamitopoulou. (2019) Tumour microenvironment of pancreatic cancer: immune landscape is dictated by molecular and histopathological features. British Journal of Cancer 121:1, pages 5-14.
Crossref
Amy L. Shergold, Rhona Millar & Robert J.B. Nibbs. (2019) Understanding and overcoming the resistance of cancer to PD-1/PD-L1 blockade. Pharmacological Research 145, pages 104258.
Crossref
Alex B. Blair, Jennifer Kleponis, Dwayne L. ThomasIIII, Stephen T. Muth, Adrian G. Murphy, Victoria Kim & Lei Zheng. (2019) IDO1 inhibition potentiates vaccine-induced immunity against pancreatic adenocarcinoma. Journal of Clinical Investigation 129:4, pages 1742-1755.
Crossref
Roberto Salvia, Fabio Casciani, Elisabetta Sereni & Claudio Bassi. (2019) Pancreatic cancer – What's next?. La Presse Médicale 48:3, pages e187-e197.
Crossref
Amedeo Sciarra, Inês Monteiro, Christine Ménétrier-Caux, Christophe Caux, Benoit Gilbert, Nermin Halkic, Stefano La Rosa, Pedro Romero, Christine Sempoux & Laurence de Leval. (2019) CD73 expression in normal and pathological human hepatobiliopancreatic tissues. Cancer Immunology, Immunotherapy 68:3, pages 467-478.
Crossref
Arsen Osipov, Adrian Murphy & Lei Zheng. 2019. Immunotherapy of Cancer. Immunotherapy of Cancer 63 144 .
Chih Kit Chung, C.G. Da Silva, Dana Kralisch, Alan Chan, Ferry Ossendorp & Luis J. Cruz. (2018) Combinatory therapy adopting nanoparticle-based cancer vaccination with immune checkpoint blockade for treatment of post-surgical tumor recurrences. Journal of Controlled Release 285, pages 56-66.
Crossref
Derya Kabacaoglu, Katrin J. Ciecielski, Dietrich A. Ruess & Hana Algül. (2018) Immune Checkpoint Inhibition for Pancreatic Ductal Adenocarcinoma: Current Limitations and Future Options. Frontiers in Immunology 9.
Crossref
Robert H. Vonderheide. (2018) The Immune Revolution: A Case for Priming, Not Checkpoint. Cancer Cell 33:4, pages 563-569.
Crossref
Jiajia Zhang, Christopher Wolfgang & Lei Zheng. (2018) Precision Immuno-Oncology: Prospects of Individualized Immunotherapy for Pancreatic Cancer. Cancers 10:2, pages 39.
Crossref
Rachel L. O. Olson, Judith V. Forner, Pilar Navarro, Martin E. Fernandez-Zapico & Ahmed M. Elamir. 2018. Pancreatic Cancer. Pancreatic Cancer 539 552 .
Rachel L. O. Olson, Judith V. Forner, Pilar Navarro, Martin E. Fernandez-Zapico & Ahmed M. Elamir. 2017. Pancreatic Cancer. Pancreatic Cancer 1 14 .
Liam Friel Tremble, Patrick F. Forde & Declan M. Soden. (2017) Clinical evaluation of macrophages in cancer: role in treatment, modulation and challenges. Cancer Immunology, Immunotherapy 66:12, pages 1509-1527.
Crossref
X Wang, M Lang, T Zhao, X Feng, C Zheng, C Huang, J Hao, J Dong, L Luo, X Li, C Lan, W Yu, M Yu, S Yang & H Ren. (2016) Cancer-FOXP3 directly activated CCL5 to recruit FOXP3+Treg cells in pancreatic ductal adenocarcinoma. Oncogene 36:21, pages 3048-3058.
Crossref
Malorye Allison Branca. (2016) Rekindling cancer vaccines. Nature Biotechnology 34:10, pages 1019-1024.
Crossref
Daniel Ansari, Bobby Tingstedt, Bodil Andersson, Fredrik Holmquist, Christian Sturesson, Caroline Williamsson, Agata Sasor, David Borg, Monika Bauden & Roland Andersson. (2016) Pancreatic cancer: yesterday, today and tomorrow. Future Oncology 12:16, pages 1929-1946.
Crossref
Masato Okamoto. (2016) Dendritic cell-based vaccine for pancreatic cancer in Japan. World Journal of Gastrointestinal Pharmacology and Therapeutics 7:1, pages 133.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.